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Abstract
Ankylosing spondylitis (AS) is a chronic inflammation of the sacroiliac joints, spine and peripheral joints. The aetiology of
ankylosing spondylitis is still unclear. Previous studies have indicated that genetics factors such as human leukocyte antigen
HLA-B27 associates to AS susceptibility. We carried out a case-control study to determine whether the genetic
polymorphisms of ORAI1 gene, a major component of store-operated calcium channels that involved the regulation of
immune system, is a susceptibility factor to AS in a Taiwanese population. We enrolled 361 AS patients fulfilled the modified
New York criteria and 379 controls from community. Five tagging single nucleotides polymorphisms (tSNPs) at ORAI1 were
selected from the data of Han Chinese population in HapMap project. Clinical statuses of AS were assessed by the Bath
Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath
Ankylosing Spondylitis Global Index (BAS-G). Our results indicated that subjects carrying the minor allele homozygote (CC)
of the promoter SNP rs12313273 or TT homozygote of the SNP rs7135617 had an increased risk of HLA-B27 positive AS. The
minor allele C of 39UTR SNP rs712853 exerted a protective effect to HLA-B27 positive AS. Furthermore, the rs12313273/
rs7135617 pairwise allele analysis found that C-G (OR 1.69, 95% CI 1.27, 2.25; p=0.0003) and T-T (OR 1.75, 95% CI 1.36, 2.27;
p,0.0001) haplotypes had a significantly association with the risk of HLA-B27-positive AS in comparison with the T-G
carriers. This is the first study that indicate haplotypes of ORAI1 (rs12313273 and rs7135617) are associated with the risk of
HLA-B27 positive AS.
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Introduction
Ankylosing spondylitis (AS) is a systemic autoimmune disease
affecting axial skeletons and peripheral joints[1]. AS ultimately
limits the mobility of the spine and other joints, contributing to
functional impairment[2]. Genetic factors have been strongly
implicated in its pathogenesis. A twin study suggested that up to
97% of AS susceptibility was attributable to genetic factors[3]. AS
was strongly associated with the human leukocyte antigen HLA-
B27 gene[4], but HLA-B27 accounted for only 16% of the genetic
load in AS[5]. HLA-B60, B61 and IL-1, IL-3R, and IL-23R
complexes also have been proven to be important in the
pathogenesis of AS[6–8]. A recent genome wide association study
(GWAS) demonstrated immune related genes such as ERAP1, and
IL-23 as strong susceptibility genes to AS[9]. Consistently, immune
related genes such as Toll-like receptor 4 and Toll-like receptor 5
are overexpressed in AS patients[10]. In addition, intergenic SNP
rs10865331 was found to be susceptible to AS in the Spanish
population[11]. MSX2 genetic polymorphisms were associated
with AS in Japanese but not Taiwanese[12]. In the Chinese Han
population, Janus kinase 2 (JAK2) polymorphisms have been
implicated to be involved in the susceptibility of AS[13]. Although
several genes have been proposed to explain the susceptibility of
AS, most genetic associations study cannot be replicated with
other populations.
Ankylosing spondylitis (AS), an inflammatory disease, affects
predominantly axial skeleton and sacroiliac joints. Therefore,
molecules involved in the regulation of calcification, autoimmune
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genes. Calcium-dependent pathways control diverse physiological
functions including enzyme metabolism, immune responses and
inflammatory activation[14]. In non-excitable cells such as T cells
and B cells, Ca
2+ entry was mainly through store-operated calcium
channels to control immunological reactions[15]. Orai1 (also
called CRACM1) consisted four transmembrane domains and
functioned as a pore forming subunit of store-operated calcium
channels[16]. Orai1 protein was highly expressed in bone tissues.
Functional studies in CRACM1 deficient mice indicated the dys-
function of mast cells, and attenuation of cytokine release (TNF-a
and IL-6)[17]. ORAI1-R91W mutations disrupt the function of
store-operated calcium channels resulting in the lack of Ca
2+
influx, defective T cell activation, and immunodeficiency[18]. Ad-
ditionally, there were lines of evidence for a role of store-operated
calcium channel in the modulation of transcription factors in-
cluding NFkB and NFAT. A great number of NFkB- and/or
NFAT-mediated genes were critical for maintaining the immune
system[19].
In this study, we examined the association between the ORAI1
polymorphisms and the risk for AS using a case-control study. The
relationship between AS activity index (BASDAI, BASFI, BAS-G),
and genetic polymorphisms of ORAI1 was also evaluated.
Materials and Methods
Study Subjects
Patients were solicited sequentially at Chung Shan Medical
University Hospital in Taichung, Taiwan. AS patients who met
selection criteria were asked to participate in the study. Informed
consent was obtained before any data was collected from the
respondents. Three selection criteria were used to recruit subjects:
(1) AS diagnosis by the modified New York criteria[20]; (2) fluent
Chinese language speakers; and (3) no obvious cognitive impair-
ment. Sacroiliitis was confirmed by a qualified radiologist or
rheumatologists, and AS diagnosis was confirmed by a qualified
rheumatologist. A total of 361 unrelated AS patients were included
in the study as cases. A detailed clinical history was recorded by
the physician at enrollment. 29 (8%) AS patients whose age are less
than 18. The mean duration of the symptoms was 7.5 years. 100%
of AS patients in this study have sacroiliitis. A total of 379 control
subjects were recruited from the general population who vol-
unteered to participate in our study while receiving a health
screening examination at the Kaohsiung Medical University Hos-
pital. All the subjects gave the consent form. The study protocol
conformed to the Declaration of Helsinki and study was approved
by the Institute Review Board of each Hospital.
Clinical Evaluations
Disease activity and functional status were assessed by the
Chinese versions of the BASDAI, the BASFI, and the Bath
Ankylosing Spondylitis Global (BAS-G) Score. Good reliability
(0.87 to 0.94) and validity (0.92 to 0.94) of these Chinese methods
have been documented[21].
Laboratory Analyses
Venous blood was collected during medical surveillance, stored
at 4uC, and processed on the same day. The blood was centrifuged
to separate the serum and the cells. All specimens were stored
under 270uC until analysis. HLA-B27 carriage had previously
been assessed by flow cytometry[22]. Genotyping is performed
using TaqMan PCR. Briefly, Taqman probes are labeled with
different fluorescent markers. PCR primers and TaqMan probes
are designed with SNP sites. Reactions are performed in 96 well
microplates with ABI 7500 thermal cycles (Applied Biosystems,
Foster City, USA). Fluorescence is measured by the ABI Real
Time PCR system. By reading the fluorescence from PCR
product, possible genotypes can be identified. Results are analyzed
with the ABI SDS software version 1.2.3.
Statistical Analysis
Genotype distributions of the five tagging single nucleotide
polymorphisms (tSNPs) were tested for Hardy-Weinberg equilib-
rium (HWE), which means the allelic distribution between all
populations and our study was not different (P.0.05). Chi-squared
test was used to compare the genotypes distribution or allele
frequencies between AS patients and controls. Analysis of variance
(ANOVA) was used to compare the mean of continuous variables
(BASDAI, BASFI, and BAS-G) among different genotypes in AS
patients. Multiple regression analysis was used to adjust for age
and sex. A p value after the Bonferroni correction less than 0.01 is
considered significant. The analyses were performed by using SAS
9.1 statistical software. Linkage disequilibrium (LD) was assessed
for any pair of SNPs and haplotype blocks were defined using the
default setting of the Haploview software[23].
Results
Basic and Clinical Characteristics of the Subjects
In this study, we selected five tSNPs of ORAI1 (rs12313273,
rs6486795, rs7135617, rs12320939, and rs712853) with minor
allele frequency .5% from the Han Chinese in Beijing (CHB)
population in the HapMap database (http://www.hapmap.org). A
graphical overview of genotyped polymorphisms was shown in
Figure 1. Two polymorphisms (rs12313273, rs12320939) of ORAI1
located in the promoter area, while two polymorphisms
(rs6486795, rs7135617) in the intron and one (rs712853) in the
39 untranslated region (UTR). A total of 361 AS patients and 379
controls were recruited in this study. Table 1 showed the
characteristics of the subjects. The mean age (years) and standard
deviation (S.D.) were 33.5612.8 for cases and 28.3615.2 for
Figure 1. A graphical overview of genotyped polymorphisms identified in relation to the exon/intron structure of the human ORAI1
gene.
doi:10.1371/journal.pone.0020426.g001
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male. 87.3% (315/361) AS subjects were HLA-B27 positive and
their mean BASDAI, mean BASFI, and mean BAS-G scores were
4.162.3, 1.962.2, and 4.362.8, respectively.
Association of ORAI1 genetic polymorphisms for the
susceptibility of HLA-B27-positive or negative patients
with AS
The genotypic frequencies of SNPs among the study subjects
were shown in Table 2, and the distribution of genotypes was in
HWE in controls. Two SNPs, rs7135617 and rs712853, showed
significant associations with HLA-B27-positive AS patients in the
recessive model. The C allele of rs712853 was associated with a
lower AS risk (OR: 0.46, P=0.002) than the rs712853 T allele.
The adjustment for age and sex did not change the association for
rs12313273 or rs712853 in the recessive model or genotype model.
The association for rs7135617 or rs712853 was still significant
even after the Bonferroni correction (P,0.01). In addition, a
borderline significant association between the genotypes and allele
frequency of rs12313273 in control subjects and HLA-B27 positive
patients was obtained with a P value=0.012 under the recessive
model. Individuals with the rs12313273 homozygous C/C
genotype had a 2.11-fold increased risk of AS compared with
those with the C/T and T/T genotypes.
No Association of ORAI1 genetic polymorphisms with the
disease activity of AS
We further analyzed the relationship between disease activity
(BASDAI, BASFI and BAS-G) and the five polymorphisms of
ORAI1 among AS patients. BASFI is strongly affected by disease
duration, therefore, adjustment for disease duration and BASFI
was performed. However, none of SNPs reached a nominal
significant level of 0.05 (Table 3). After adjustment for the effects
of age and sex, the polymorphisms of ORAI1 still failed to show
any significant association with the severity of AS (Table 3). Subset
analysis on cases with HLA-B27 positive or negative did not yield
any significant results (data not shown).
Haplotype Analysis of ORAI1 genetic polymorphisms in
the susceptibility of HLA-B27-positive or negative
patients with AS
We calculated pairwise linkage disequilibrium (LD) (Figure 2)
and analyzed three common haplotypes using the Haploview 4.2
program and PHASE version 2.1, respectively. The haplotype
frequency of rs12313273/rs7135617 among the study subjects was
shown in Table 4. rs12313273/rs7135617 pairwise allele analysis
indicated that C–G (AOR =1.69; 95% CI, 1.27–2.25; P=
0.0003), and T-T (AOR =1.75; 95% CI, 1.36–2.27; P,0.0001)
had a significant association with the risk of HLA-B27-positive AS
in comparison with the T-G haplotype under a recessive model.
Table 1. Basal characteristics and clinical features of patients
with ankylosing spondylitis (AS) and of normal controls.
Characteristics Patients with AS Normal Controls
Number of subjects 361 379
Gender:male, No (%) 245 (67.9%) 265 (69.9%)
a
Age (years)
b 33.5612.8 28.3615.2
c
Range 6–69 18–80
HLA-B27(+) 315 (87.3%)
BASDAI (0–10) 4.162.3
BASFI (0–10) 1.962.2
BAS-G (0–10) 4.362.8
aP=0.546 +.
bmeans 6 S.D.
cP,0.0001.
doi:10.1371/journal.pone.0020426.t001
Table 2. Genotyping and allele frequency of ORAI1 tSNP in HLA-B27(+) or HLA-B27(-) with ankylosing spondylitis (AS) and controls.
Genotype
HLA-B27(+)
(n=315) (%)
HLA-B27(-)
(n=46) (%)
Control Subjects
(n=379) (%)
Recessive
Odds ratio
{
Recessive P
Value
{
Recessive
Odds ratio
{
Recessive P
Value
{
rs12320939 TT 68 (22.2) 15 (32.6) 90 (26.1) 0.89 0.511 1.68 0.138
GT 142 (46.4) 22 (47.8) 165 (47.8)
GG 96 (31.4) 9 (19.6) 90 (26.1)
rs12313273 CC 34 (10.9) 7 (15.6) 20 (5.7) 2.11 0.012 3.32 0.015
CT 116 (37.3) 18 (40.0) 148 (41.8)
TT 161 (51.8) 20 (44.4) 186 (52.5)
rs7135617 TT 72 (23.2) 6 (13.7) 60 (17.0) 1.70 0.008* 0.90 0.817
GT 139 (44.9) 21 (47.7) 164 (46.6)
GG 99 (31.9) 17 (38.6) 128 (36.4)
rs6486795 CC 50 (16.1) 10 (22.2) 54 (15.6) 1.13 0.581 1.91 0.108
CT 126 (40.7) 21 (46.7) 159 (45.8)
TT 134 (43.2) 14 (31.1) 134 (38.6)
rs712853 CC 25 (8.1) 1 (2.2) 59 (16.2) 0.46 0.002* 0.13 0.045
CT 109 (35.3) 24 (52.2) 153 (42.0)
TT 175 (56.6) 21 (45.6) 152 (41.8)
*Significant (P,0.01) values are in bold.
{Adjusted the effects of age and sex for HLA-B27 positive patients compared with controls.
{Adjusted the effects of age and sex for HLA-B27 negative patients compared with controls.
doi:10.1371/journal.pone.0020426.t002
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HLA-B27-negative AS patients (Table 4).
No Association between ORAI1 Haplotypes and the
disease activity of AS
We further analyzed the relationship between disease activity
and rs12313273/rs7135617 haplotypes among AS patients. As
shown in table 5, none of the rs12313273/rs7135617 pairwise
allele analysis tested in this study showed a significant association
between AS and BASDAI, BASFI, and BAS-G. After adjustment
for the effects of age, gender and disease duration, the haplotype
analysis of rs12313273/rs7135617 still failed to show any sig-
nificant results with the disease activity of AS.
Discussion
Our results first revealed that genetic polymorphisms of ORAI1
rs12313273 (located in the promoter), rs7135617 (located in the
intron) and rs712853 (located in the 39UTR) were associated with
susceptibility to AS in a Taiwanese population. Results from pairwise
allele analysis for rs12313273/rs7135617 indicated that C-G and T-
T haplotypes associated with a significantly higher risk of HLA-B27
positive AS in comparison with the T-G haplotypes. Several lines of
evidence indicated the importance of SNPs at the promoter and
39UTR in gene expression. Studies showed that a promoter SNP of
Table 3. Difference in the scores of BASDAI, BASFI, and BAS-G
among AS patients stratified by different ORAI1 alleles.
SNP Alleles BASDAI BASFI BAS-G
rs12320939 T/T 4.162.4
a 1.762.1 4.162.9
G/T 4.162.3 1.962.1 4.262.8
G/G 4.362.3 2.162.4 4.562.8
Unadjusted P-value 0.86 0.52 0.57
Adjusted P-value 0.86
{ 0.51
1 0.57
{
rs12313273 C/C 3.262.3 1.362.1 3.362.8
C/T 4.462.4 1.962.1 4.462.8
T/T 4.262.2 2.162.3 4.462.9
Unadjusted P-value 0.02 0.14 0.10
Adjusted P-value 0.02
{ 0.12
1 0.09
{
rs7135617 T/T 4.362.3 2.362.5 4.762.9
G/T 4.162.3 2.062.2 4.162.8
G/G 4.162.4 1.661.9 4.262.8
Unadjusted P-value 0.72 0.12 0.46
Adjusted P-value 0.72
{ 0.09
1 0.46
{
rs6486795 C/C 3.762.3 1.562.0 3.562.7
C/T 4.262.3 1.962.1 4.262.7
T/T 4.262.2 2.262.4 4.662.9
Unadjusted P-value 0.40 0.19 0.10
Adjusted P-value 0.40
{ 0.17
1 0.10
{
rs712853 C/C 3.961.9 2.362.0 4.362.7
C/T 4.262.1 1.862.1 4.262.8
T/T 4.162.5 2.062.3 4.362.9
Unadjusted P-value 0.88 0.64 0.95
Adjusted P-value 0.88
{ 0.61
1 0.95
{
aData represent means 6 S.D.
{Adjusted the effects of age and sex.
1Adjusted the effects of age, sex and disease duration.
doi:10.1371/journal.pone.0020426.t003
Figure 2. ORAI1 gene LD and haplotype block structure in AS.
The number on the cell is the LOD score of D’.
doi:10.1371/journal.pone.0020426.g002
Table 4. Haplotype frequency of the ORAI1 gene in HLA-B27(+) or HLA-B27(-) patients with ankylosing spondylitis and controls.
rs12313273/rs7135617
HLA-B27(+)
(n=315) (%)
HLA-B27(-)
(n=46) (%)
Control Subjects
(n=379) (%) AOR (95% CI)
{ P Value
{ AOR (95% CI)
{ P Value
{
C/G 184 (30.0) 30 (33.3) 186 (26.8) 1.69 (1.27–2.25) 0.0003* 1.65 (0.95–2.87) 0.078
T/T 280 (45.6) 34 (37.8) 282 (40.6) 1.75 (1.36–2.27) ,0.0001* 1.25 (0.73–2.13) 0.413
T/G 150 (24.4) 26 (28.9) 226 (32.6) Reference Reference
*Significant (P,0.05) values are in bold.
{Adjusted the effects of age and sex for HLA-B27 positive patients compared with controls.
{Adjusted the effects of age and sex for HLA-B27 negative patients compared with controls.
doi:10.1371/journal.pone.0020426.t004
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development of AS via attenuation of TNF-a gene expression [24].
Furthermore, SNPs at the 39UTR may interfere with mRNA
stability or protein translation by interacting with microRNAs[25].
MicroRNAs have been shown to play a critical role in the regulation
of gene expression in immune diseases, including psoriatic arthritis
susceptibility[26]. A recent study demonstrated that a 39UTR
polymorphisms of IL-1R associated kinase (IRAK1)g e n ew a s
associated with rheumatoid arthritis (RA) susceptibility[26]. The
RA-associated SNP of IRAK1 was in the binding site of microRNA-
146a[26]. Results obtained in IRAK1 implied that 39UTR
polymorphism at ORAI1 might affect susceptibility to AS via similar
mechanisms (microRNA-relevant expression alteration).
Despite the strong association of HLA-B27 gene with AS, other
genes within and/or outside the MHC were reported to involve in
the susceptibility of AS[6,8,9]. Wei et al[8]. found that HLA-B60
and HLA-B61 genes were associated with AS development among
HLA-B27 negative patients which might be due to the similar T-cell
epitopes of HLA-B60 and HLA-B27 [27]. In vivo, the inflammation
in the joint destruction was regulated by IL-1a and IL-1b, and IL-1
receptor antagonist (IL-1Ra) combined with IL-1 receptor to inhibit
the IL-1[28]. In addition, the genetic variants in the IL-1F10.3, IL-
1RN.4, IL-1RN.VNTR, IL-1RN6/1 and IL-1RN6/2 were
significantly associated with occurrence of AS [29]. Shiau et al.,
observed that the distribution of TNF-a G-238A genotypes and
alleles, as well as that of G-308A genotypes and alleles, between AS
patients and controls were significantly different[30]. Both IL-1b
and TNF-a pathways coordinated multiple signaling events leading
to the increase of intracellular calcium concentration [31].
Association study in Chinese Han population revealed that JAK2
played an important role in the susceptibility to AS [13]. The
increase of cytosolic calcium resulted in the activation of JAK-
STAT pathways, which, in turn, involved in the regulation of
proinflammatory genes [32]. Our association studies in AS provided
some indirect evidence that supported a role of calcium signaling in
the susceptibility to AS. Therefore, to understand the functional role
of ORAI1 polymorphisms in the regulation of JAK2/STAT
pathways may gain more insight to the disease pathogenesis.
Calcium influx through store-operated calcium channels has
been shown its importance in a variety of diseases such as hy-
pertension, arterial injury and severe combined immunodeficiency
disease (SCID)[33]. A point mutation of ORAI1 that resulted in the
reduction of store-operated Ca
2+ influx and cytokine release was
found in the SCID patients[18]. The biophysical characteristics of
store-operated calcium channel can be altered by the changed
composition of heteromeric ORAI channels. The Ca
2+ selectivity of
homomeric ORAI1 or ORAI3 was higher than that of heteromeric
ORAI1 and ORAI3[34]. Additionally, knockdown of ORAI1 can
inhibit cell proliferation via attenuation of store-operated Ca
2+
influx [35,36]. Importantly, overexpression of ORAI1 may in-
fluence the successful coupling between ORAI subunits or lose
sensitivity to the store-depletion signals that lead to the dysfunction
of store-operated calcium channel [37,38]. The expression level of
ORAI subunits hence could significantly contribute to the
intracellular Ca
2+ mobilization and physiological functions. The
mechanism of how ORAI1 gene being regulated is still unclear.
Our results indicated that genetic polymorphisms of ORAI1
(rs12313273 and rs712853) were associated with the risk of AS.
With these findings, our study may offer a clue to better under-
stand the regulation mechanism of ORAI1.
In conclusion, our research was the first study to pinpoint the
association between genetic polymorphisms of ORAI1 and the risk
of AS. Our study indicated that haplotypes of rs12313273/
rs7135617 had a significantly association with the risk of
HLA-B27-positive AS but none of them was associated with
theHLA-B27-negatve AS. We attribute this to the case number (46
HLA-B27negative AS patients), due to a small statistical power.
Another possible explanation, that should be mentioned, is that
these haplotypes are associated with the HLA- B27 per se and not
exactly to AS.
We also analyzed the relationship between age of onset, hip
involvement, erythrocyte sedimentation rate (ESR), C reactive
protein (CRP) and ORAI1 genotypes. However, no statistically
significant association between genotypes and phenotypes were
found (data not shown).We acknowledged that the sample size in
the study was under-powered to detect the small genetic effect of
ORAI1 in the disease activity such as BASDAI/ BASFI, BAS-G.,
ESR or CRP. These findings need to be replicated in another
population with a larger sample size.
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